A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men

CONTEXT: A novel formulation of oral testosterone (T) undecanoate (TU) was evaluated in a phase 3 clinical trial. OBJECTIVE: Determine efficacy, short-term safety, and alignment of new oral TU formulation with current US approval standards for T replacement therapy. DESIGN: Randomized, active-contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Swerdloff, Ronald S, Wang, Christina, White, William B, Kaminetsky, Jed, Gittelman, Marc C, Longstreth, James A, Dudley, Robert E, Danoff, Theodore M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282712/
https://www.ncbi.nlm.nih.gov/pubmed/32382745
http://dx.doi.org/10.1210/clinem/dgaa238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282712/
https://www.ncbi.nlm.nih.gov/pubmed/32382745
http://dx.doi.org/10.1210/clinem/dgaa238

Ejemplares similares